Key stats
Fund info
Home page
Inception date
Aug 13, 2021
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Primary advisor
CI Investments, Inc.
ISIN
CA12567E1097
CUSIP
12567E109
FIGI
BBG01237LVC0
Identifiers
ISIN CA12567E1097
The fund specifically represents the healthcare space within developed markets. It includes companies engaged in medical distributions, hospital/nursing management and services, pharmaceuticals, biotech, drugstore chains, and other medical specialties. Eligible securities are ranked by market-cap, and the top 135 securities are selected for inclusion with considerations to succeeding ranks until the portfolio reaches 150 constituents. Holdings are market-cap-weighted and are rebalanced on a quarterly basis. The fund may include firms of all sizes, however, its market-cap-focused strategy skews the fund towards large-caps.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.90%
Health Technology86.80%
Health Services9.16%
Distribution Services2.59%
Retail Trade1.27%
Commercial Services0.09%
Bonds, Cash & Other0.10%
Cash0.10%
Breakdown by region
North America70.57%
Europe23.85%
Asia3.93%
Oceania1.22%
Middle East0.43%
Latin America0.00%
Africa0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently asked questions
CHCL.B invests in stocks. The fund's major sectors are Health Technology, with 86.80% stocks, and Health Services, with 9.16% of the basket. The assets are mostly located in the North America region.
CHCL.B top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 10.82% and 5.92% of the portfolio correspondingly.
CHCL.B last dividends amounted to 0.07 CAD. The quarter before, the issuer paid 0.06 CAD in dividends, which shows a 13.31% increase.
CHCL.B assets under management is 135.63 M CAD. It's fallen 2.42% over the last month.
CHCL.B fund flows account for 39.55 M CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
CHCL.B shares are issued by CI Financial Corp. under the brand CI. The ETF was launched on Aug 13, 2021, and its management style is Passive.
CHCL.B expense ratio is 0.56% meaning you'd have to pay 0.56% of your investment to help manage the fund.
CHCL.B follows the Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CHCL.B invests in stocks.
CHCL.B price has fallen by −1.56% over the last month, and its yearly performance shows a 13.01% increase. See more dynamics on CHCL.B price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.51% over the last month, have fallen by −0.51% over the last month, showed a −0.26% decrease in three-month performance and has increased by 13.97% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −0.51% over the last month, have fallen by −0.51% over the last month, showed a −0.26% decrease in three-month performance and has increased by 13.97% in a year.
CHCL.B trades at a premium (0.23%) meaning the ETF is trading at a higher price than the calculated NAV.